Skip to main content

FDA recall, , Moderate risk

Erbe USA ERBECRYO 2 Cryosurgical Unit

The ERBECRYO 2 Cryosurgical Unit can rupture its cryoprobe due to excessive pressure from a strong pull on the hose.

What happened

Erbe USA Inc, of Marietta, Georgia, recalled the ERBECRYO 2 Cryosurgical Unit. A strong pull on the high-pressure transfer hose of the cryosurgical unit may lead to a pneumatic short circuit between the gas inlet and the connector, resulting in CO2 leaking into the return path, leading to excessive pressure causing the cryoprobe to rupture. The recall began on June 26, 2026, and was added to the FDA's Enforcement Report on August 12, 2026.

The recalled units were distributed nationwide across the United States, including its states and territories. The FDA classified the recall on August 12, 2026, and it was in the FDA's weekly enforcement report on August 19, 2026.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Compare the details below with your product and check the FDA notice to confirm whether it is affected.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. ERBECRYO 2 Cryosurgical Unit

    Model number
    • 10402-000
    UDI-DI
    • 04050147013797
    • 11608268
    Lot code
    All serial numbers up to 11608268 Software Version: 1

Recall details

Company began the recall
Sold in

US Nationwide distribution including in the states and territories of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Company
Erbe USA IncMarietta, Georgia
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99341
Recall number
Z-2938-2026
Quantity recalled
11226 units

All recalls from Erbe USA Inc

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 25, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)